Horizon 2020 Marie Sklodowska-Curie Actions

These are the latest news on to the Marie Sklodowska-Curie Actions under the Horizon 2020 “Excellent Science”, the European Programme for Research and Innovation to take over the FP7 starting January 2014:

• will have an estimated budget of € 5,450 million for the period 2014-2020

• will have a bottom-up approach (not ruled by topics)

• will finance 100% of the eligible costs (excluding co-founded)

• will be open to researchers and innovation staff, universities, research organizations, companies, etc.., of all countries (including third countries under certain conditions)

• will pay particular attention to encouraging the participation of enterprises, particularly SMEs, to improve the success and impact of the projects

• will have the requisite of mobility. Researchers will receive funding to move from country to country and expand or deepen their skills

Actions types:

Marie Sklodowska-Curie Innovative Training Networks (ITN)

Objective: To empower a new generation of researchers (Early-Stage Researchers) to address current and future challenges and turn knowledge and ideas into products and services for the benefit of society and the European economy. Three types of networks will financed: European Training Network (ETN), European Industrial Doctorate (EID) and Joint Doctorate (EJD).

Estimated opening date: December 2013.

Marie Sklodowska-Curie Research and Innovation Staff Exchange (RISE)

Objective: To promote international and intersectoral collaboration through the exchange of researchers and innovation, and knowledge transfer to the advancement of science and innovation development.

Estimated opening date: September 2014.

Marie Sklodowska-Curie Individual Fellowships (IF)

Objective: To support the career development of experienced researchers in both the public and private sectors and in the international arena. Particularly support to the return of researchers who are outside Europe and who previously worked in a European country.

Estimated opening date: December 2013.

Marie Sklodowska-Curie Co-funding of Regional, National and International Programmes (co-founded)

Objective: To co-finance regional programmes, national and international recruitment of researchers involving transnational mobility.

Estimated opening date: July 2014.

European Researchers’ Night (NIGHT)

Objective: To support participation in the “Night of the researchers,” an event involving pan-European scientific organizations of different types. It includes a series of activities that aim to bring researchers to the general public to enhance their role in society.

Estimated opening date: December 2013.

4th Scientific BIOCAPS Seminar 2013: Chemistry and Cancer: From Causes to Diagnosis and Therapy

logo_biocaps_seminario

logo_biocaps_4logos

The Biomedical Research Institute of Vigo (IBIV), within the framework of the European project BIOCAPS (Capacities Biomedical Support Programme), organize their 4th Scientific Seminar on the subject of chemistry and cancer. It will be held at the “Experimental Science building” of the University of Vigo, December 20th, from 8:30 h.

1st International Congress on Biomedical Research & Innovation

logo_biocaps_seminario

logo_biocaps_4logos

The Institute of Biomedical Research of Vigo (IBIV), within BIOCAPS´ Project Framework, will celebrate the “1st International Congress on Biomedical Research & Innovation” on the 21st and 22nd of November 2013 in Vigo, Spain.

The event will highlight the most important R&D aspects related to the Biomedical Research and Innovation in the following fields:

  • Neurological sciences and rare diseases
  • Infectious diseases, Inflammation and Immunity
  • Endocrinology, Metabolism and Nutrition
  • Biomaterials, Tissue engineering and Regenerative Medicine
  • New tools in diagnosis and therapy
  • Ageing and cardiovascular diseases
  • Biomedical Innovation

In each field, renowned researchers will expose their studies. Also, abstracts for poster presentations are welcome and must be submitted via the congress web, www.ibiv-biocaps-congress.es, where additional information about congress and inscription can be found.

The congress is expected to become a point of reference for Biomedical Research and Innovation, transmitting scientific perspective and awareness among scientists, public bodies, enterprises and the society.

Conference on advances in molecular biology by young researchers abroad

logo_sei2013

The National Center of Biotechnology of CSIC celebrates in December 19 in Madrid the 21st edition of its traditional day “Advances in molecular biology by young researchers abroad”. This invitation goes to all Spanish postdoctoral scientists working abroad and coming home for Christmas.

The conference will end with a round table which will discuss the various funding possibilities within the Spanish scientific system .

Attendance is free for everybody. Everyone is invited, this includes: researchers from the universities, other centers of CSIC, as CNIO centers, CNIC, CIEMAT, ISCIII, INIA, hospitals and biotechnology companies.

How to participate as a speaker? (as listeners, we are all invited)

1. – You must meet the basic requirement of being postdoctoral and work outside Spain .

2 . – Prepare the following information:

  • title (short, very short!) of your communication
  • e- mail (to be included in the program)
  • name of the main researcher
  • workplace
  • if you think your work is important enough to be presented at the joint session, indicate so specifically and briefly explains why, including, where appropriate, a reference to a work published or in press.
  • in the case that you had to travel within Spain, indicate from where and approximate the kilometers to Madrid.

3 . – Submit your application by Friday, November 30, 2013, to any of the following e-mails indicating the profile in which you are most comfortable

For further information, you can contact the Spanish Society of Immunology at gestionSEI@inmunologia.org

Call for Letters of Intent: Clinic and Laboratory Integration Program (CLIP)

logo_cri

The Cancer Research Institute (CRI) is requesting letters of intent for its Clinic and Laboratory Integration Program (CLIP). CRI offers CLIP grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support basic, pre-clinical, and translational research, which will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.

  • LOI Deadline: November 1, 2013
  • Funding: Up to $100,000 per year for two years

Inquiries may be directed to grants@cancerresearch.org

Second International Conference on Clinical & Cellular Immunology

logo_omics

In October 15-17, the Immunology Summit 2013 will be celebrated at the Hampton Inn Tropicana, Las Vegas, USA. The theme will be “Disseminating the New Trends in Immunology”. The Organizing Committee of Immunology Summit-2013 has worked closely with the OMICS Group Conference organizers to bring together researchers from the United States and countries world-wide to discuss in open forum significant recent research advances in Immunology.

To accomplish this goal, they developed 15 separate tracks for this meeting which cover the relevant topics in basic molecular and cellular immunology as well as clinical immunology. These include the broad areas of cytokine and inflammation research, autoimmunity and the major disease states, cancer, infection and immunodeficiency syndromes, as well as reproductive immunology, transplantation, and allergy.

Link: more info

Contact:

  • Charlas Malemud
  • Professor of Medicine, Division of Rheumatic Diseases
  • Case Western Reserve University School of Medicine Cleveland, Ohio 44106 USA
  • Editor-in-Chief, Journal of Clinical and Cellular Immunology

Resource: OMICS Group Conference

BioNanoMed 2014 – 5th International Congress

logo_bionanomed

The 5th International Congress BioNanoMed 2014 (Nanotechnology Enables Personalized  Medicine) will be held on 26 – 28 March 2014 at the International Meeting Centre Krems/Austria.

In addition to prominent invited speakers a limited number of talks and poster presentations can be accepted. You are cordially invited to submit your short abstract!

SCIENTIFIC PROGRAM

Topics

  • Novel Nanomedical Solutions – Advances in Nanomedicine
  • Nanomaterials for Biomedical Applications
  • Nano-Oncology: Diagnostic, Drug Delivery and Therapy
  • NanoPharmaceuticals & Production Technologies

Thematic Sessions

  • Nano-Bio-Sensing: New Sensing Approaches, Visions and Perspectives in Diagnosis & Therapy
  • Nano- Imaging-Technologies in Medicine
  • NanoSafety: Innovation-Enabler for Nanomedicine

Special Session

  • Nanotechnology for Artifical Organ Support (organized by ESAO – European Society of Artificial Organs)

POSTER AWARDS

Erwin Schrödinger Society Poster Awards 2014 are granted to the three best poster contributions (€ 300 for the first, € 200 for the second and € 100 for the third place) and Nanotoxicology Award by BioNanoNet Forschungs GmbH (€ 250,-).

EXHIBITION & SPONSORING

BioNanoMed 2014 serves as an excellent platform to present your company/institution, to promote your product portfolio and to establish direct links to a broad audience of experts. By becoming an exhibitor or sponsor you will make a great contribution to support the BioNanoMed 2014 congress.

IMPORTANT DATES

Deadline for oral abstracts: 17 December 2013
Deadline for poster abstracts: : 9 March 2014
End of early registration: 31 January 2014
End of online registration: 821 March 2014

For more information, please go to http://www.bionanomed.at or contact the conference office at office@bionanomed.at

bionanomed2014.pdf (1.2 MB)

1 16 17 18 19 20 21